Shuyun Zhou Selected Research

Shuyun Zhou Research Topics

18	Neoplasms (Cancer) 01/2022 - 04/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2014 - 12/2011
3	Leukemia 12/2011 - 04/2005
2	Ischemic Stroke 02/2023 - 01/2020
1	Ischemia 02/2023
1	Wounds and Injuries (Trauma) 02/2023
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020
1	Hypoxia (Hypoxemia) 04/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2012
1	Mycoses (Diseases, Fungus) 08/2010
1	Candidiasis (Moniliasis) 08/2010
1	Residual Neoplasm 04/2005

3	CarbonIBA 01/2020 - 04/2018
2	hydroxide ionIBA 02/2023 - 12/2020
2	PorphyrinsIBA 05/2021 - 09/2019
1	Ferritins (Ferritin)IBA 02/2023
1	Neuroprotective AgentsIBA 02/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023
1	Atorvastatin (Lipitor)FDA Link 02/2023
1	BoronIBA 12/2021
1	tetracarboxyphenylporphineIBA 05/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Free RadicalsIBA 01/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	CopperIBA 01/2020
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2020
1	IronIBA 09/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2019
1	Metal-Organic FrameworksIBA 09/2019
1	Oxygen (Dioxygen)IBA 04/2018
1	RutheniumIBA 04/2018
1	Disulfiram (Antabuse)FDA Link 09/2014
1	Decitabine FDA Link 02/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2011
1	disulfiram-copperIBA 12/2011
1	FluorineIBA 08/2010
1	Deoxyglucose (2 Deoxy D glucose)IBA 08/2010

12	Therapeutics 02/2023 - 08/2010
5	Precision Medicine 01/2022 - 07/2017
4	Photothermal Therapy 01/2022 - 01/2019
3	Phototherapy (Light Therapy) 12/2021 - 09/2019
2	Photochemotherapy (Photodynamic Therapy) 09/2019 - 01/2018
1	Quantum Dots (Quantum Dot) 11/2020
1	Nanospheres 01/2019
1	Drug Therapy (Chemotherapy) 12/2011
1	Transplantation 04/2005
1	Hematopoietic Stem Cell Transplantation 04/2005